PTK6 may collaborate with a range of growth factor receptors, including as the ERBB family, IGF1R, and MET, as well as a variety of signaling pathways, such as hypoxia, p27/CDK/Cyclins, ERK1/2/P38 to promote tumor progression [39–41]. This evidence concerns the gene MET and neoplasm.